As of the latest SEC filings, Eikon Therapeutics, Inc. (EIKN) is held by 38 institutional funds. The largest fund shareholder is Fidelity Contrafund (FCNTX), holding an estimated $13,497,964.00 in market value, representing 0.01% of its portfolio.
Funds holding Eikon Therapeutics, Inc. (EIKN)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- EIKN
- CIK:
- 0001861123
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FCNTX
Fidelity Contrafund
|
MF | Fidelity | 0.01% | $13,497,964.00 | 1,275,800 | Mar 31, 2026 | May 26, 2026 |
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.01% | $12,099,679.46 | 1,143,637 | Mar 31, 2026 | May 28, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.15% | $9,954,520.42 | 722,389 | Feb 27, 2026 | Apr 24, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.08% | $7,592,208.00 | 717,600 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $7,532,081.86 | 711,917 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.01% | $6,010,836.00 | 436,200 | Feb 28, 2026 | Apr 24, 2026 |
|
QUAZX
AB Small Cap Growth Portfolio
|
MF | Independent / Boutique | 0.16% | $4,718,743.94 | 490,769 | Apr 30, 2026 | Jun 24, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.08% | $4,204,112.64 | 305,088 | Feb 28, 2026 | Apr 24, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.03% | $3,693,456.84 | 349,098 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.03% | $3,503,672.80 | 331,160 | Mar 31, 2026 | May 28, 2026 |
|
FLCNX
Fidelity Contrafund K6
|
MF | Fidelity | 0.01% | $2,844,686.92 | 268,874 | Mar 31, 2026 | May 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $2,497,144.50 | 236,025 | Mar 31, 2026 | May 28, 2026 |
|
BILPX
BlackRock Event Driven Equity Fund
|
MF | BlackRock / iShares | 0.03% | $1,711,944.52 | 124,234 | Feb 27, 2026 | Apr 24, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.01% | $1,701,830.00 | 123,500 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.01% | $1,536,470.00 | 111,500 | Feb 28, 2026 | Apr 24, 2026 |
|
PGRTX
SmallCap Growth Fund I
|
MF | Independent / Boutique | 0.06% | $1,335,206.21 | 138,867 | Apr 30, 2026 | Jun 25, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.13% | $1,286,824.24 | 121,628 | Mar 31, 2026 | May 28, 2026 |
|
FBTDX
Franklin Biotechnology Discovery Fund
|
MF | Franklin Templeton | 0.12% | $1,224,720.24 | 127,376 | Apr 30, 2026 | Jun 24, 2026 |
|
BME
BlackRock Health Sciences Trust
|
CEF | BlackRock / iShares | 0.13% | $668,846.44 | 63,218 | Mar 31, 2026 | May 28, 2026 |
|
-
Health Sciences Portfolio
|
ETF | Independent / Boutique | 0.13% | $455,998.00 | 43,100 | Mar 31, 2026 | May 27, 2026 |
|
-
AVIP AB Small Cap Portfolio
|
ETF | Independent / Boutique | 0.09% | $257,644.16 | 24,352 | Mar 31, 2026 | May 29, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.00% | $163,596.16 | 11,872 | Feb 28, 2026 | Apr 28, 2026 |
|
SWTSX
Schwab Total Stock Market Index Fund
|
MF | Charles Schwab | 0.00% | $134,610.00 | 14,000 | Apr 30, 2026 | Jun 25, 2026 |
|
VBINX
VANGUARD BALANCED INDEX FUND
|
MF | Vanguard | 0.00% | $126,949.42 | 11,999 | Mar 31, 2026 | May 28, 2026 |
|
VITNX
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND
|
MF | Vanguard | 0.00% | $100,404.20 | 9,490 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)